Aristo Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1971.
1971 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Aristo Pharmaceuticals Private Limited

Aristo Pharmaceuticals Private Limited, a active private limited company, was established on 08 November 1971 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239MH1971PTC015425. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹9.90 M and a paid-up capital of ₹9.90 M.

Formerly known as Aristo Pharmaceuticals Limited. It upholds a compliant status. Employing 9,848 professional, Its leadership includes Randhir Kumar Bachan (Whole-Time Director), Virendra Sharma (Director), Umesh Sharma (Managing Director). Past directors included Raj Nandan Sharma, Randhir Kumar Bachan, Ranjit Sharma. It holds no open charges and ₹7.61 Cr settled loans. Its latest AGM occurred on 05 September 2025, with the balance sheet filed on 31 March 2025. It is based at Gala No.2,Ground Floor,23-A Shah Industrial Estate Off Veera Desai Road, Andheri(West), Mum, Bai 400053, Mumbai, Maharashtra, 400053.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239MH1971PTC015425

  • Registration Number

    015425

  • Incorporation Date

    08 November 1971

  • Authorized Capital

    ₹9.90 M

  • Paid-Up Capital

    ₹9.90 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 9.90 M
  • Paid Up Capital ₹ 9.90 M
  • Company Age 54 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 7.61 Cr
  • Revenue Growth **** 12.09%
  • Profit Growth **** 16.92%
  • Ebitda **** 10.41%
  • Net Worth 19.13%
  • Total Assets **** 18.13%
Company report

Aristo Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aristo Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Aristo Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Randhir Kumar Bachan Whole-Time Director 01 Sep 2005 Current
Virendra Sharma Director 03 Oct 2006 Current
Umesh Sharma Managing Director 12 Feb 1979 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 21 Sep 2017 Past
Pramod Abcsdd Director 01 Sep 2005 Past
Pramod Abcsdd Director 23 Jun 2011 Past
Pramod Abcsdd Director 22 May 2008 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aristo Pharmaceuticals.

Aristo Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 12.09% increase. The company also saw a substantial improvement in profitability, with a 16.92% increase in profit. The company's net worth Soared by an impressive increase of 19.13%.

Aristo Pharmaceuticals revenue growth over time
Aristo Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 12.09%
*******
*******
*******
*******
Revenue from Operations
*******
 8.81%
*******
*******
*******
*******
Total Assets
*******
 18.13%
*******
*******
*******
*******
Profit or Loss
*******
 16.92%
*******
*******
*******
*******
Net Worth
*******
 19.13%
*******
*******
*******
*******
EBITDA
*******
 10.41%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aristo Pharmaceuticals?

In 2024, Aristo Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹76,070,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 5.05 Cr
  • Bank Of India : 1.00 Cr
  • Srate Bank Of India : 1.00 Cr
  • Bank Of India : 0.40 Cr
  • State Industrial & Investment Corporation : 0.16 Cr
Latest Charge Details
Date Lender Amount Status
04 Mar 1993 Srate Bank Of India ₹1.00 Cr Satisfied
08 Aug 1988 State Bank Of India ₹5.05 Cr Satisfied
11 Dec 1980 Bank Of India ₹4.00 M Satisfied
14 Nov 1980 Bank Of India ₹4.00 M Satisfied
10 Mar 1979 Bank Of India ₹5.30 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Aristo Pharmaceuticals?

Aristo Pharmaceuticals has a workforce of 9848 employees as of Feb 17, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aristo Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aristo Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aristo Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Aristo Pharmaceuticals Private Limited last Annual general meeting of members was held on 05 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Aristo Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Charges

    The activity A charge registered on 11 Dec 1980 via Charge ID 90223705 with Bank Of India was fully satisfied on 06 Dec 2023. was completed.

  • Charges

    The activity A charge registered on 14 Nov 1980 via Charge ID 90223702 with Bank Of India was fully satisfied on 06 Dec 2023. was completed.

  • Charges

    A charge registered on 10 Mar 1979 via Charge ID 90223681 with Bank Of India was fully satisfied on 06 Dec 2023. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 25 Feb 1974 via Charge ID 90223630 with Bank Of India was fully satisfied on 06 Dec 2023. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Aristo Pharmaceuticals Private Limited?

The CIN of Aristo Pharmaceuticals Private Limited is U24239MH1971PTC015425.

Where is Aristo Pharmaceuticals Private Limited headquartered?

Aristo Pharmaceuticals Private Limited is headquartered at Gala No.2,Ground Floor,23-A Shah Industrial Estate Off Veera Desai Road, Andheri(West), Mum, Bai 400053, Mumbai, Maharashtra, 400053.

When was Aristo Pharmaceuticals Private Limited incorporated?

Aristo Pharmaceuticals Private Limited was incorporated on 08 November 1971.

Who are the current directors of Aristo Pharmaceuticals Private Limited?

The current directors of Aristo Pharmaceuticals Private Limited are

What is the primary industry of Aristo Pharmaceuticals Private Limited?

The primary industry of Aristo Pharmaceuticals Private Limited is Manufacturing.

Is Aristo Pharmaceuticals Private Limited a listed company?

Aristo Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Aristo Pharmaceuticals Private Limited?

The authorized capital of Aristo Pharmaceuticals Private Limited is ₹9.90 M, and the paid-up capital is ₹9.90 M.

What is the compliance status of Aristo Pharmaceuticals Private Limited?

The compliance status of Aristo Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available